Saint-Care (2374) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
9 Sep, 2025Executive summary
Revenue increased 3.0% year-over-year to ¥13,808 million for the first quarter, but operating profit declined 22.2% and net profit attributable to shareholders fell 21.4% due to higher personnel costs and new business openings.
The business environment remains challenging with rising demand for services amid a shrinking workforce and regulatory changes, including a 2024 triple revision of care, medical, and disability welfare fees.
The company responded to regulatory changes and prioritized solutions for high medical-need clients, while also advancing its "Community No.1 Strategy" and expanding through M&A and new openings.
Financial highlights
Operating profit for Q1 was ¥610 million, down 22.2% year-over-year; ordinary profit was ¥643 million, down 18.7%.
Net profit attributable to shareholders was ¥381 million, a 21.4% decrease year-over-year.
Comprehensive income for the quarter was ¥387 million, down 20.8% year-over-year.
EPS for Q1 was ¥15.43, compared to ¥19.64 in the prior year.
Total assets at quarter-end were ¥29,918 million, down from ¥30,987 million at the previous year-end.
Outlook and guidance
Full-year revenue is forecast at ¥57,120 million (up 5.7% year-over-year), with operating profit of ¥3,300 million (up 8.8%) and net profit of ¥2,135 million (up 6.5%).
No change to previously announced full-year guidance; any future revisions will be disclosed as needed.
Full-year EPS is projected at ¥86.68.
Latest events from Saint-Care
- Sales up, profits mixed, and full-year outlook projects lower earnings despite growth.2374
Q3 202613 Feb 2026 - Sales and profit rose, but full-year outlook signals lower operating profit ahead.2374
Q2 202626 Nov 2025 - Revenue up 3.8% year-over-year, but profits fell; full-year outlook remains positive.2374
Q2 20259 Sep 2025 - Sales up, profits down; outlook sees higher sales but lower earnings and increased dividends.2374
Q3 20259 Sep 2025 - Sales rose but profits fell; recovery is forecasted for next year.2374
Q4 20259 Sep 2025 - Strong year-over-year profit growth and positive full-year outlook with higher dividends.2374
Q1 20269 Sep 2025